HCAT vs. AVAH

Last updated Apr 1, 2026

Compare and contrast key facts about Health Catalyst, Inc. (HCAT) and Aveanna Healthcare Holdings Inc. (AVAH).

Performance

HCAT vs. AVAH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Health Catalyst, Inc. (HCAT) and Aveanna Healthcare Holdings Inc. (AVAH). The values are adjusted to include any dividend payments, if applicable.

HCAT vs. AVAH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
HCAT Health Catalyst, Inc.	-46.86%	-66.20%	-23.65%	-12.89%	-73.17%	-30.00%
AVAH Aveanna Healthcare Holdings Inc.	-21.18%	78.77%	70.52%	243.59%	-89.46%	-38.33%

Fundamentals

Market Cap HCAT : $90.17M AVAH : $1.38B
EPS HCAT : -$2.53 AVAH : $1.04
PS Ratio HCAT : 0.29 AVAH : 0.57
PB Ratio HCAT : 0.37 AVAH : 7.12
Total Revenue (TTM) HCAT : $311.14M AVAH : $2.43B
Gross Profit (TTM) HCAT : $151.68M AVAH : $810.48M
EBITDA (TTM) HCAT : -$112.59M AVAH : $213.57M

Returns By Period

In the year-to-date period, HCAT achieves a -46.86% return, which is significantly lower than AVAH's -21.18% return.

HCAT

• 1D: 7.63%
• 1M: -21.60%
• YTD: -46.86%
• 6M: -55.44%
• 1Y: -71.96%
• 3Y*: -52.26%
• 5Y*: -51.67%
• 10Y*: —

AVAH

• 1D: 0.94%
• 1M: -12.50%
• YTD: -21.18%
• 6M: -27.40%
• 1Y: 18.82%
• 3Y*: 83.63%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

HCAT vs. AVAH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HCAT

HCAT Risk / Return Rank: 4
HCAT Sharpe Ratio Rank: 5
HCAT Sortino Ratio Rank: 3
HCAT Omega Ratio Rank: 5
HCAT Calmar Ratio Rank: 5
HCAT Martin Ratio Rank: 3

AVAH

AVAH Risk / Return Rank: 55
AVAH Sharpe Ratio Rank: 52
AVAH Sortino Ratio Rank: 59
AVAH Omega Ratio Rank: 56
AVAH Calmar Ratio Rank: 54
AVAH Martin Ratio Rank: 53

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HCAT vs. AVAH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Health Catalyst, Inc. (HCAT) and Aveanna Healthcare Holdings Inc. (AVAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HCAT	AVAH	Difference
Sharpe ratio Return per unit of total volatility	-1.00	0.27	-1.27
Sortino ratio Return per unit of downside risk	-1.82	1.13	-2.95
Omega ratio Gain probability vs. loss probability	0.79	1.13	-0.35
Calmar ratio Return relative to maximum drawdown	-0.95	0.51	-1.46
Martin ratio Return relative to average drawdown	-1.87	1.06	-2.93
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HCAT vs. AVAH - Sharpe Ratio Comparison

The current HCAT Sharpe Ratio is -1.00, which is lower than the AVAH Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of HCAT and AVAH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	HCAT	AVAH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.00	0.27	-1.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.78	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.62	-0.15	-0.47

Correlation

The correlation between HCAT and AVAH is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

HCAT vs. AVAH - Dividend Comparison

Neither HCAT nor AVAH has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

HCAT vs. AVAH - Drawdown Comparison

The maximum HCAT drawdown since its inception was -98.13%, roughly equal to the maximum AVAH drawdown of -94.76%. Use the drawdown chart below to compare losses from any high point for HCAT and AVAH.

Drawdown Indicators

	HCAT	AVAH	Difference
Max Drawdown Largest peak-to-trough decline	-98.13%	-94.76%	-3.37%
Max Drawdown (1Y) Largest decline over 1 year	-75.77%	-38.75%	-37.02%
Max Drawdown (5Y) Largest decline over 5 years	-98.13%	—	—
Current Drawdown Current decline from peak	-97.83%	-50.04%	-47.79%
Average Drawdown Average peak-to-trough decline	-61.52%	-64.30%	+2.78%
Ulcer Index Depth and duration of drawdowns from previous peaks	38.54%	18.85%	+19.69%

Volatility

HCAT vs. AVAH - Volatility Comparison

Health Catalyst, Inc. (HCAT) has a higher volatility of 38.55% compared to Aveanna Healthcare Holdings Inc. (AVAH) at 12.45%. This indicates that HCAT's price experiences larger fluctuations and is considered to be riskier than AVAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HCAT	AVAH	Difference
Volatility (1M) Calculated over the trailing 1-month period	38.55%	12.45%	+26.10%
Volatility (6M) Calculated over the trailing 6-month period	55.52%	31.69%	+23.83%
Volatility (1Y) Calculated over the trailing 1-year period	72.21%	69.95%	+2.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.46%	78.47%	-12.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	64.89%	78.47%	-13.58%

Financials